- Telehealth Visits
- Insurance plan information
Gregory Ku, MD, PhD
Diabetes- Telehealth Visits
- Insurance plan information
Gregory Ku, MD, PhD
Diabetes- Telehealth Visits
- Insurance plan information
On this page
About me
Dr. Gregory Ku is an endocrinologist who cares for patients with all types of diabetes.
Ku’s research focuses on the beta cells of the pancreas, which normally produce insulin but are either destroyed or dysfunctional in type 1 and type 2 diabetes. In order to better treat diabetes, he investigates how to improve beta cell function, survival and proliferation.
Ku earned his doctorate in biomedical sciences as well as his medical degree in the UCSF Medical Scientist Training Program. He completed a residency in internal medicine and a fellowship in diabetes, endocrinology and metabolism at UCSF. He is a member of the American Diabetes Association.
Education & training
Board certification
- Endocrinology Diabetes & Metab, American Board of Internal Medicine
Fellowship
- Endocrinology, UCSF Medical Center - OMAG
Residency
- Internal Medicine, UCSF Medical Center - OMAG
Internship
- Internal Medicine, University of CA at San Francisco School of Med
Degree
- MD, UCSF School of Medicine
My expertise
Specialties
Conditions
- Adrenal Disorders
- Pituitary Disorders
- Thyroid Nodule
- Hypothyroidism
- Hypogonadism
- Hyperthyroidism
- Hyperparathyroidism
- Goiter
- Diabetes Mellitus
Locations
Clinical Trials query: q=health_gateway_id_ss%3A%28%221074%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%221074%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.